A New York Based Pediatric Oncology Developmental Therapeutics Program |
Columbia University / Julia Glade Bender, MD |
Phase I/II Infrastructure Grants |
2010 |
New York |
In-UTR Mutations in Neuroblastoma: Functional Consequences and Therapeutic Implications |
Children’s Hospital of Philadelphia / Andrei Thomas-Tikhonenko |
Innovation Grants |
2010 |
Pennsylvania |
The role of PDE4B in Racial Disparities in Outcome of Childhood Acute Lymphoblastic Leukemia |
St. Jude Children’s Research Hospital / Jun Yang |
Young Investigator Grants |
2010 |
Tennessee |
Identification of New Therapeutic Targets in Pediatric Acute Lymphoblastic Leukemia Through Mosaic Trisomy and Aneuploidy-Based Synthetic Lethality Screens |
Dana-Farber Cancer Institute / David Pellman |
Innovation Grants |
2010 |
Massachusetts |
Characterization and Targeting of Novel Activating BRAF Mutations in Pediatric Brain Tumors |
Children’s Hospital of Philadelphia / Angela Waanders, MD, MPH |
Young Investigator Grants |
2010 |
Pennsylvania |
Pathogenesis of T-cell Acute Lymphoblastic Leukemia from Myeloproliferative Disorder |
Duke University / Motonari Kondo |
Innovation Grants |
2010 |
North Carolina |
Molecular diagnostic, prognostic, and therapeutic approaches toward Ewing sarcoma.
|
Huntsman Cancer Institute / Stephen Lessnick |
Innovation Grants |
2009 |
Utah |
Identifying Rare Genetic Variants Involved in High Risk Pediatric Leukemia Via Pooled Sequencing |
Washington University / Todd Druley, MD, PhD |
'A' Award Grants |
2009 |
Missouri |
Metabolic control of p53 activation in T-ALL.
|
Duke University / Jeffrey Rathmell |
Innovation Grants |
2009 |
North Carolina |
Neuronal Damage, Neurocognitive Losses and Quality of Life Following High-Dose Chemotherapy in Children with Brain Tumors |
Children’s Hospital Los Angeles / Mary Nelson |
Nurse Researcher Grants |
2009 |
California |